Literature DB >> 25486184

ccRCC is fundamentally a metabolic disorder.

Apostolos Zaravinos1, Constantinos Deltas.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25486184      PMCID： PMC4615011          DOI： 10.4161/15384101.2014.947225

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  Brick by brick: metabolism and tumor cell growth.

Authors:  Ralph J Deberardinis; Nabil Sayed; Dara Ditsworth; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2008-04-02       Impact factor: 5.578

Review 2.  The genetic basis of kidney cancer: a metabolic disease.

Authors:  W Marston Linehan; Ramaprasad Srinivasan; Laura S Schmidt
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

3.  Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

Authors:  John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Michael L Blute
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

Review 4.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 5.  Metabolism of kidney cancer: from the lab to clinical practice.

Authors:  Sunil Sudarshan; Jose A Karam; James Brugarolas; R Houston Thompson; Robert Uzzo; Brian Rini; Vitaly Margulis; Jean-Jacques Patard; Bernard Escudier; W Marston Linehan
Journal:  Eur Urol       Date:  2012-09-28       Impact factor: 20.096

6.  A clear picture of renal cell carcinoma.

Authors:  A Ari Hakimi; Can G Pham; James J Hsieh
Journal:  Nat Genet       Date:  2013-08       Impact factor: 38.330
  6 in total
  2 in total

1.  MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.

Authors:  Minjiang Huang; Ti Zhang; Zhi-Yong Yao; Chaoqung Xing; Qingyi Wu; Yuan-Wu Liu; Xiao-Liang Xing
Journal:  BMC Med Genomics       Date:  2021-03-09       Impact factor: 3.063

2.  PBRM1 deficiency oncogenic addiction is associated with activated AKT-mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells.

Authors:  Yu Tang; Yan-Hong Jin; Hu-Li Li; Hui Xin; Jin-Dong Chen; Xue-Ying Li; You-Fu Pan
Journal:  J Cell Mol Med       Date:  2022-06-07       Impact factor: 5.295
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.